Ley Sander MD PhD FRCP FEAN FMedSci MAE, qualified at the University of Parana, in Curitiba, Brazil, completed his neurological training at St Thomas Hospital and then obtained his PhD at University College London. He is a Professor of Neurology and Head of the Department of Clinical and Experimental Epilepsy at UCL Queen Square Institute of Neurology. He is a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is the Director of the Chalfont Centre for Epilepsy in Buckinghamshire, UK and the R&D Director of Stichting Epilepsie Instellingen Nederland (SEIN) in The Netherlands. The Chalfont Centre, which he leads, is a major hub for clinical and translational epilepsy research and is internationally recognised as a standard-setting centre in all aspects of epilepsy care and research. Sander’s research interests are in the epidemiology, genetics and co-morbidities of epilepsy, the management of chronic epilepsy and care delivery in resource-poor settings. He has over 900 publications, including original research articles, books and book chapters (GS metrics: >49,000 citations, h-index: 113). He is an elected Fellow of the Academy of Medical Sciences, a Fellow of the Royal College of Physicians, a Fellow of the European Academy of Neurology and a member of the Academia Europaea. Sander has obtained many postgraduate awards, including the Research Recognition Award for Clinical Sciences from the American Epilepsy Society, the Innovation and Sustainability in Health Award, the BUPA Foundation Epidemiology Award, the European Gower's Prize, the Bateman Award for the Alleviation of Epilepsy, the ILAE/IBE Ambassador for Epilepsy Award and the Baldev Singh Award for Clinical Neurosciences from the Indian Academy of Neurology.